Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Omnicell, Inc.

Market Cap 1.72B 1.49B 1.38B 1.29B 2.41B 165B 2.46B 16.41B 6.35B 79.39B 6.46B 6.32B 276B P/E Ratio 2026 *
48.5x
P/E Ratio 2027 * 38.3x
Enterprise Value 1.72B 1.49B 1.38B 1.29B 2.41B 165B 2.46B 16.41B 6.35B 79.39B 6.46B 6.32B 276B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.31x
Free-Float
76.29%
Yield 2026 *
-
Yield 2027 * -
1 day-0.94%
1 week-13.26%
Current month-14.32%
1 month-12.66%
3 months+0.91%
6 months-12.64%
Current year-16.51%
1 week 36.55
Extreme 36.55
43.52
1 month 36.55
Extreme 36.55
45
Current year 31.75
Extreme 31.75
55
1 year 26.84
Extreme 26.845
55
3 years 22.66
Extreme 22.66
75.07
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 68 1992-08-31
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Director

4,627 0.0102%
05-31Free

Director

4,785 0.0105%
05-31Free

Director

5,027 0.0111%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-13.26%+24.45%-47.65% 1.72B
-1.35%-9.55%-44.01%-13.89% 26.24B
+0.45%-1.18%-41.35%+150.48% 11.9B
-3.20%+1.89%-8.70%+59.30% 6.1B
+4.21%+6.46% - - 2.65B
-1.75%-12.04% - - 1.66B
+3.61%+0.95%-32.02% - 1.26B
-3.29%-3.55%-35.35%-60.11% 807M
-3.00%-5.16%-34.03%+209.72% 767M
+3.80%+5.77%-33.25%-41.17% 784M
Average -0.14%-2.25%-25.53%+36.67% 5.39B
Weighted average by Cap. -0.73%-4.33%-35.88%+36.95%

Financials

2026 *2027 *
Net sales 1.25B 1.08B 998M 935M 1.75B 119B 1.78B 11.9B 4.61B 57.57B 4.68B 4.58B 200B 1.32B 1.14B 1.05B 986M 1.84B 126B 1.88B 12.55B 4.86B 60.71B 4.94B 4.83B 211B
Net income 35.72M 30.99M 28.57M 26.77M 50.02M 3.42B 51.06M 341M 132M 1.65B 134M 131M 5.73B 45.83M 39.77M 36.66M 34.35M 64.18M 4.39B 65.52M 437M 169M 2.12B 172M 168M 7.35B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change Volume
26-06-11 37.82 $ -0.94% 1,376,379
26-06-10 38.18 $ -6.17% 792,199
26-06-09 40.69 $ -3.00% 692,073
26-06-08 41.95 $ -2.44% 583,754
26-06-05 43.00 $ -1.38% 337,278
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
37.82USD
Average target price
61.29USD
Spread / Average Target
+62.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!